Since Jan 2015, Selleckchem products have been cited in 46 studies from top scientific journals.
- Nature, 2017, 541(7638):481-487
- Nature, 2017, 10.1038/nature21064
- Nature, 2016, 539(7627):54-58
- Nature, 2016,540(7631):119-123
- Nature, 2016, 539(7629):437-442
- Nature, 2016, 539(7628):304-308
- Nature, 2016, 538(7626):477-482
- Nature, 2016, 535(7613):517-22
- Nature, 2016, 537(7620):422-426
- Nature, 2016, 530(7590):358-61
- Nature, 2016, 534(7607):341-6
- Nature, 2016, 32(7597):107-11
- Nature, 2016, 531(7596):651-5
- Nature, 2015, 528(7582):422-6
- Nature, 2015, 522(7557):492-6
- Nature, 2015, 527(7576):100-4
-Nature-20170210.gif)
-Nature-20170210.gif)
-Nature-20170210.gif)
- Nature, 2015, 522(7556):349-53
- Nature, 2015, 521(7552):316-21
- Nature, 2015, 521(7553):541-4
- Nature, 2015, 520(7549):683-7
- Nature, 2015, 518(7538):254-7
- Nature, 2015, 517(7534):391-5
- Nature, 2015, 522(7555):226-30
- Nature, 2015, 517(7535):460-5
- Nature, 2015, 523(7558):92-5
- Nature, 2015, 521(7552):357-61
- Nature, 2015, 520(7547):368-72
- Nature, 2015, 524(7566):471-5
- Nature, 2015, 517(7536):583-8
- Nature, 2015, 519(7543):370-3
- Science, 2017, eaal3755
- Science, 2017, 355(6320):78-83
- Science, 2017, 355(6320):84-88
- Science, 2016, 354(6315)
- Science, 2016, 351(6277):aad3680
- Science, 2016, 352(6283):353-8
- Science, 2016, 352(6282):189-96
- Science, 2016, 353(6302):929-32
- Cell, 2017, 168(5):856-866
- Cell, 2017, 168(1-2):86-100
- Cell, 2016, 167(1):233-247
- Cell, 2016, 167(7):1803-1813
- Cell, 2016, 164(1-2):293-309
- Cell, 2016, 165(1):234-46
- Cell, 2015, 162(2):441-51
- Cell, 2015, 160(1-2):161-76
-Isethionate-Science-20170215.gif)
-Cell-20170214.gif)
-Cell-20170214.gif)
Customer Product Validations
Nature, 2016, 537(7620):422-427.
Nature, 2015,520(7547):368-72.
FRA1 downregulation during RAFi treatment drives the reactive
secretome.
c, In A375 cells treated in vitro with vehicle or vemurafenib for 6 or
48 h. Relative mRNA levels of FRA1 during vemurafenib exposure [0.1-1 uM]. d, Representative
immunofluorescence staining of A375/A375R tumours for GFP (A375R, green) and FRA1 (red) after
vehicle or vemurafenib treatment (5 days). DAPI, 4',6-diamidino-2-phenylindole. Scale bars, 50
um.
Overnight Delivery
Signaling Pathway Center
Rewards Program
Inhibitor Expert
